home / stock / lly / lly articles

LLY Articles, Eli Lilly and Company - From 02/17/24

Stock Information
Company Name: Eli Lilly and Company
Stock Symbol: LLY
Market: NYSE
Website: lilly.com
Menu
LLY LLY Quote LLY Short LLY News LLY Articles LLY Message Board
Get LLY Alerts

News, Short Squeeze, Breakout and More Instantly...
Warren Buffett's Empire Nears Trillion-dollar Club As Class A Shares Hit Above $600,000 | Benzinga

This week, Berkshire Hathaway (NYSE: BRK-A) achieved a historic milestone as its Class A shares closed above $600,000 for the first time. The surge...
UK Becomes First Major Market for Eli Lilly's Mounjaro Prefilled Pen For Tackling Obesity | Benzinga

Pharmaceutical giant Eli Lilly And Co (NYSE:LLY) is set to launch its highly-anticipated obesity drug, Mounjaro (tirzepatide), in Britain...

What's Gaining Popularity Among US Teens Battling Obesity? Novo Nordisk's Weight Loss Drug Wegovy | Benzinga

A growing number of U.S. adolescents, facing record rates of pediatric obesity, are reportedly turning to Novo Nordisk A/S’s (NYSE:...

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $6,000 Today | Benzinga

Eli Lilly (NYSE:LLY) has outperformed the market over the past 5 years by 31.12% on an annualized basis producing an average annual return of 43.4%...
Jim Cramer Warns Weight Loss Drugs Ozempic, Wegovy And Others Could Impact Food Stocks: 'That Day Will Come' | Benzinga

Jim Cramer, the host of CNBC’s “Mad Money,” has issued a warning to investors about the potential impact of weight loss drugs, su...

Eli Lilly's Weight Loss Drug Tirzepatide Is Expanding Market Share, Analyst Outlines What Lies Ahead (CORRECTED) | Benzinga

Editor’s note: The headline and body of this story have been update to correct the name of Eli Lilly’s drug tirzepatide. In support of...

Eli Lilly's Weight Loss Drug Tripeptide Is Expanding Market Share, Analyst Outlines What Lies Ahead | Benzinga

In support of expectations for Eli Lilly And Company’s (NYSE:LLY) tripeptide, BMO Capital Markets is tracking weekly Mounjaro, Zepbound, GL...
Novo Nordisk, Eli Lilly Stride To Boost Supply Shortage For Newly Found Holy Grail Of Miraculous Weight Loss Drugs | Benzinga

The unprecedented demand for weight loss drugs, including Novo Nordisk A/S’s (NYSE:NVO) Wegovy and Eli Lilly And Co’s&nb...

Is Tesla Still A Magnificent 7 Stock? EV Maker Could Get Bumped By These Companies | Benzinga

Tesla‘s (NASDAQ:TSLA) standing within the Magnificent Seven is in question. What Happened: The Austin, Texas-based electric vehicle (EV) com...

Jim Cramer Says Investors Should Look Beyond Apple, Meta And Other Magnificent 7 Stocks: 'You Might Be Missing Out On Some Huge Gains' | Benzinga

Jim Cramer, the host of CNBC’s “Mad Money,” has suggested that investors should look beyond the Magnificent Seven tech stocks for...
Previous 10 Next 10